Riik: Iirimaa
keel: inglise
Allikas: HPRA (Health Products Regulatory Authority)
SODIUM LACTATE, SODIUM CHLORIDE PH.EUR., POTASSIUM CHLORIDE PH. EUR., CALCIUM CHLORIDE DIHYDRATE PH. EUR.
Dechra Limited
QB05BB01
SODIUM LACTATE, SODIUM CHLORIDE PH.EUR., POTASSIUM CHLORIDE PH. EUR., CALCIUM CHLORIDE DIHYDRATE PH. EUR.
Unknown
Solution for Infusion
POM
Bovine, Canine, Equine - Food, Feline
Electrolytes
Electrolytes
Authorised
2013-08-09
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT VETIVEX 11 (Hartmann's) solution for infusion for cattle, horses, dogs and cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Solution for infusion. Clear, colourless solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, horses, dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES This veterinary medicinal product is administered by intravenous infusion for the treatment of dehydration and metabolic acidosis in cattle, horses, dogs and cats. It may be used to correct volume depletion (hypovolaemia) resulting from gastrointestinal disease or shock. 4.3 CONTRAINDICATIONS Lactate-containing solutions will not be utilised effectively in animals with hepatic impairment and it is undesirable to use this veterinary medicinal product in animals with metabolic alkalosis. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 1ml contains: Active substances: Sodium Lactate 3.20 mg Sodium Chloride 6.00 mg Potassium Chloride 0.40 mg Calcium Chloride 0.20 mg (equivalent to Calcium Chloride Dihydrate 0.27 mg) Sodium: 131 mmol/litre Potassium: 5 mmol/litre Calcium: 2 mmol/litre Bicarbonate (as lactate): 29 mmol/litre Chloride: 111 mmol/litre For a full list of excipients, see section 6.1. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 14/12/2016_ _CRN 7023834_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals: Do not use unless the solution is clear, free from visible particles, and the container is undamaged. A risk of thrombosis with intravenous infusion should be considered. Maintain aseptic precautions. This veterinary medicinal product should be warmed to appro Lugege kogu dokumenti